bioRxivNeurosciencePreprint
Study the dynamics of behavioral and biochemical parameters in the PARK2-knock-out mice model of Parkinson's disease
E. Y. EmelianovaiD, Olga A. AverinaiD, Oleg A. Permyakov, Anastasia V. Priymak, Mariia A. EmelianovaiD, O. A. GrigoryevaiD, Svetlana A. Garmash, Сергиев Петр ВладимировичiD, Olga U. Frolova, Kirill E. KianitsaiD, V. Yu. SavitskiyiD, Maxim L. LovatiD
Abstract
BackgroundParkinsons disease (PD) is a progressive chronic neurodegenerative disease. The PARK2 gene encoding the Parkin protein accounts for approximately half of early-onset autosomal recessive PD cases in humans. ObjectiveThe aim of this work was to study the effect of the PARK2 gene knockout in mice on the dynamics of behavioral and biochemical parameters of PD. MethodsThe study was performed on C57BL/6-line mice aged from 4 months to 1.5 years: wild type (park2 +/+), heterozygotes (park2 +/-) and homozygotes (park2 -/-) knocked out by the PARK2 using CRISPR-Cas9. The open field test, the Porsolt forced swimming test, the grid-walk test, the beam-walking test, the elevated plus maze test, the accelerating rotarod test were used to assess the behavioral phenotype. Measurement of the concentration of bioamines and their metabolites by HPLC and evaluation of the amount of tyrosine hydroxylase, BDNF and GDNF by Western Blot were used to study the biochemical signs of PD. ResultsPark2 -/- mice begin to show signs of decreased motor activity no earlier than at 4 months of life. At 12 months of life, it was shown only a decrease in the level of the mature isoform of GDNF and an increase in the number of immature isoforms in the frontal cortex and striatum were revealed. ConclusionThe data obtained indicates a different age dynamic of the condition of mice associated with the PARK2 knockout. However, no pronounced specific manifestations of PD in human were found in park2 -/- mice.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combined knockout of Lrrk2 and Rab29 does not result in behavioral abnormalities in vivo
M. C. Mazza, V. Nguyen, … M. R. Cookson·Journal of Parkinson's DiseasePeer-reviewed·Apr 13, 2021
- Sex- and age-dependent control of dopamine function by LRRK2, and rapid reversal of dopamine release deficits in the LRRK2-G2019S knock-in mouse model of Parkinson's Disease.
Christina Gentle, Anusha Kamesh, … Austen J. Milnerwood·bioRxiv·Oct 16, 2026
- Kir4.2 deficiency drives progressive Parkinson's disease-like motor, cognitive and neuropathological phenotypes in mice
Benjamin Garland, Zhiqiang Shen, … Linlin Ma·bioRxiv·May 4, 2026
- Characterization of Nonmotor Symptoms in the MitoPark Mouse Model of Parkinson's Disease
Monica Renee Langley, Shivani Ghaisas, … Anumantha G Kanthasamy·bioRxiv·Nov 2, 2020
- Nonmotor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson's disease
Anna Radlicka-Borysewska, Judyta Jabłońska, … Jan M. Rodriguez Parkitna·bioRxiv·Jan 23, 2023
- Dopamine neuron dysfunction and loss in the PrknR275W mouse model of Juvenile Parkinsonism
Maria Regoni, Letizia Zanetti, … Jenny Sassone·BrainPeer-reviewed·Oct 1, 2024